TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive NCI Study Fails To Support Finding Of Excess Cancer In Utah Nuclear Fallout Areas January 23, 1987
TCL Archive Clinical Instigator Object To HEW Proposal On Compensation Notification In Consent Forms December 15, 1978
TCL Archive DCE Board Approves New Study to Seek Causes Of Rising Breast Cancer Incidence In Young Women May 27, 1988
